Carolyn Bonner

Carolyn Bonner

No open positions remaining

Net worth: 7 165 $ as of 31/05/2026

42 year
Health Services
Health Technology
Finance

Profile

Carolyn Bonner is currently Director at SkinJect, Inc. since 2023, Director-Business Development at PLUS Diagnostics, Inc., and President & Chief Financial Officer at Medicus Pharma Ltd. starting in 2025.
Former roles include President & Chief Executive Officer at Parkway Clinical Laboratories, Inc. from 2019 to 2023, Director-Corporate Development at Rosetta Genomics Ltd. from 2008 to 2009, Director-Corporate Development at Building Beyond BRIC Investment Fund LP from 2019 to 2023, and President at Interactive Capital Partners Corp.
Education includes undergraduate studies at West Chester University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.03%
03/06/2026 18,905 ( 0.03% ) 7 165 $ 31/05/2026

Carolyn Bonner active positions

CompaniesPositionStart
Director/Board Member 18/10/2023
Corporate Officer/Principal -

Former positions of Carolyn Bonner

CompaniesPositionEnd
Building Beyond BRIC Investment Fund LP
Corporate Officer/Principal 01/01/2023
Chief Executive Officer 01/01/2023
ROSETTA GENOMICS LTD. Corporate Officer/Principal 01/05/2009
President -
See the detail of Carolyn Bonner's experience

Training of Carolyn Bonner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

6

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Finance

Consumer Services

Health Services

Health Services

Building Beyond BRIC Investment Fund LP

Health Services

  1. Stock Market
  2. Insiders
  3. Carolyn Bonner